• Zahraa Ahmed Okhti Department of Clinical Laboratory Sciences, College of Pharmacy, Al-Mustansiriyah University, Baghdad, Iraq
  • Muthanna I. Al-ezzi Department of Pharmacology and Toxicology, College of Pharmacy, Al-Mustansiriyah University, Baghdad, Iraq
  • Raghad Abdulmahdi Department of Pharmacology and Toxicology, College of Pharmacy, Al-Mustansiriyah University, Baghdad, Iraq



Flaxseed Lignan, Secoisolariciresinol, Diglucoside


Objective: The objective of the study was to investigate the effect of dietary flaxseed-derived lignan supplement as anti-hyperlipidemic (fatty liver changes) on rabbit liver.

Methods: Rabbits were assigned randomly into three groups (five rabbits for each group): group-1, normal diet (negative control); group-2, 1.6 % cholesterol diet for 30 d (positive control) and group-3, 1.6 % cholesterol for 30 d then gave 40 mg/kg/day of pure flax lignan for 14 d.

Results: Marked proliferation of fibrous connective tissue infiltrated with mononuclear cells was recorded; congested dilated of sinusoids and fibrosis in the portal area around the proliferation of bile ducts and congested portal blood vessels with the proteinous material in the lumen of bile ducts were also recorded. In other sections, the liver showed large necrotic area replacement with RBCs as well as enlarged foamy hepatocytes with mononuclear cells in narrowing sinusoids were seen.

Conclusion: From the results of this study we can conclude that lignan has been used successfully in decreasing the inflammatory cells in congested blood vessels and sinusoids and has decreased the inflammatory cells infiltration in moderate fibrosis in the portal area around the bile ducts of rabbit liver tissue.


Download data is not yet available.


Cerovic I, Mladenovic D, Jesic R, Naumovic T, Brankovic M, and Vucevic D, et al. Alcoholic liver disease/non C alcoholic fatty liver disease index: distinguish alcoholic from the non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2013;25:899-904.

Bodakhe SH, Gupta SK. Diagnostic methods for non-alcoholic fatty liver diseases alternative to liver biopsy: a review. Asian J Pharm Clin Res 2015;8:54-9.

Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol 2006;290:G852-8.

Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician 2006;73:1961-8.

Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–31.

Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005;50:171–80.

Saad CT, Précoma DB, Merlini AB, Ioshii SO, Champosk NF. Evaluation of flaxseed effects on non-alcoholic fatty liver disease (NAFLD) in rabbits submitted to a hypercholesterolemic diet. Funct Foods Health Dis 2014;4:442-50.

Prasad K. Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits. J Cardiovasc Pharmacol Ther 2009;14:38-48.

Davin LB, Lewis NG. Dirigentphenoxy radical coupling: advances and challenges. Curr Opin Biotechnol 2005:16:398-406.

Singha AK, Chawlab V, Sarafc SK, Keshari A. Different chemical, biological and molecular approaches for antihyperlipidemic therapy with spacial emphases on anti-hyperlipidemic agents of natural origin. J Crit Rev 2014;1:1-9.

Abid DA, Soulimane NM, Merzouk H, Narce M. Linseed oil supplementation improves lecithin cholesterol acyltransferase and tissue lipase activities in obese pregnant rats and their offspring. Int J Pharm Pharm Sci 2016;8:194-200.

Patel D, Vaghasiya J, Pancholi SS, Paul A. Therapeutic potential of Seco iso lariciresinol glucoside: a plant lignan. Int J Pharm Sci Drug Res 2012;4:15-8.

Bhathena SJ, Velasquez MT. The beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002;76:1191–201.

Li X, Yuan JP, Xu SP, Wang JH, Liu X. Separation and determination of Seco iso lariciresinol glucoside oligomers and their hydrolysates in the flaxseed extract by high-performance liquid chromatography. J Chromatogr A 2008;1185:223–32.

Fossati P, Prencipe L. Serum Triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.

Carleton HM, Drury RA, Wallington EA. Carleton’s histological technique. 5th Ed. Oxford University Press: USA; 1980. p. 520.

Hubscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006;49:450–65.

Nawras A Alwan. Effect of chicorium intybus extracts on histological changes in liver and kidney of hypercholesterolemic rabbits. Bas J Vet Res 2009;8:98-107.

Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.

Kim EJ, Kim BH, Seo HS, Lee YJ, Kim HH, Son HH, et al. Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS One 2014;9:e97841.

Zanwar AA, Hegde MV, Bodhankar SL. Antihyperlipidemic effect of flax lignan concentrate in triton induced hyperlipidemic rats. Int J Pharmacol 2012;8:355-63.

Imran M, Ahmad N, Anjum FM, Khan MK, Mushtaq Z. Potential protective properties of flax lignan secoisolariciresinol diglucoside. Nutr J 2015;14:71.

Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M. Flaxseed lignan attenuates high-fat-diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 2008;100:669–76.

Pandey M, kuamar V. Nutraceutical supplementation for diabetes: a review. Int J Pharm Pharm Sci 2011;3:33-40.



How to Cite

Okhti, Z. A., M. I. Al-ezzi, and R. Abdulmahdi. “THE PROTECTIVE ROLE OF FLAXSEED LIGNAN IN MALE RABBITS WITH HIGH-FAT DIET: HISTOPATHOLOGICAL STUDY”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 11, Nov. 2016, pp. 90-94, doi:10.22159/ijpps.2016v8i11.13323.



Original Article(s)